APL-102 Capsule in Patients With Advanced Solid Tumors

Clinical trial NCT05055518 · SUSPENDED

Trial details

NCT number: NCT05055518
Sponsor: Apollomics Inc.
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-08-02
Primary completion: 2028-10-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.